Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 4/20 | 0.37 |
| ▸ | FPR2 | P25090 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.35 |
| ▸ | PYGL | P06737 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.33 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.33 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12462486 | 0.92 | FOLH1 (0.45) | PYGLFOLH1 | |
| SCHEMBL12374471 | 0.91 | FOLH1 (0.46) | ABL1FOLH1 | |
| SCHEMBL21065294 | 0.90 | NAALAD2 (0.47) | FPR2FOLH1 | |
| SCHEMBL12462485 | 0.90 | NAALAD2 (0.47) | FPR2FOLH1 | |
| SCHEMBL12462479 | 0.88 | JAK2 (0.41) | ABL1FPR2PYGLFOLH1 | |
| SCHEMBL12374469 | 0.88 | USP2 (0.40) | — | |
| SCHEMBL21065264 | 0.84 | TDP1 (0.43) | NPSR1 | |
| SCHEMBL21065266 | 0.84 | TDP1 (0.43) | NPSR1 | |
| SCHEMBL12374464 | 0.81 | TUBB4A (0.33) | ABL1 | |
| SCHEMBL13051269 | 0.80 | GAA (0.38) | ABL1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11141368-B2 | Cosmetic composition, cosmetic treatment method, kit, and compound | L'OREAL (FR) | 2021-10-12 | — | — | US | disclosed |
| US-10813866-B2 | Cosmetic composition, cosmetic treatment method, kit, and compound | L'OREAL (FR) | 2020-10-27 | — | — | US | disclosed |
| EP-2521530-B1 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, KIT, AND COMPOUND | OREAL (FR) | 2019-06-26 | — | — | EP | disclosed |
| US-8575341-B2 | Cosmetic composition, cosmetic treatment method, and compound | L'OREAL (FR) | 2013-11-05 | — | — | US | disclosed |
| US-8575341-B2 | Cosmetic composition, cosmetic treatment method, and compound | L'OREAL (FR) | 2013-11-05 | — | — | US | disclosed |
| US-20130017162-A1 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, KIT, AND COMPOUND | L'OREAL (FR) | 2013-01-17 | — | — | US | disclosed |
| US-20130017162-A1 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, KIT, AND COMPOUND | L'OREAL (FR) | 2013-01-17 | — | — | US | disclosed |
| US-20110189118-A1 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, AND COMPOUND | L'OREAL (FR) | 2011-08-04 | — | — | US | disclosed |
| US-20110189118-A1 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, AND COMPOUND | L'OREAL (FR) | 2011-08-04 | — | — | US | disclosed |
| WO-2011080494-A2 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, KIT, AND COMPOUND | L'OREAL (FR) | 2011-07-07 | — | — | WO | disclosed |
| WO-2010001041-A2 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, AND COMPOUND | L'OREAL (FR) | 2010-01-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130017162-A1 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, KIT, AND COMPOUND | KRT18, KIT, TYR | ABL1 1039/4885FPR2 1666/4885MAPK1 969/4885 |
| US-20110189118-A1 | COSMETIC COMPOSITION, COSMETIC TREATMENT METHOD, AND COMPOUND | KRT18, MC1R, C1R | ABL1 4705/4885FPR2 1609/4885MAPK1 2828/4885 |
| US-10813866-B2 | Cosmetic composition, cosmetic treatment method, kit, and compound | KRT18, KIT, TYR | ABL1 1039/4885FPR2 1666/4885MAPK1 969/4885 |
| US-11141368-B2 | Cosmetic composition, cosmetic treatment method, kit, and compound | KRT18, KIT, TYR | ABL1 1039/4885FPR2 1666/4885MAPK1 969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.